LATS2 and breast carcinoma: Moreover, deletion of Lats2 nearly abolished the death of cultured PyMT mouse tumor cells upon RGZ treatment (Fig 5I), further confirming that sensitivity of lumB breast cancer cells to PPARγ activation is LATS2 dependent.